The case involves an application filed under Regulation 45(3)(a) of the IBBI (Liquidation Process) Regulations, 2016, by the Liquidator of Ariston Pharma Nova Tech Private Limited, seeking closure of the liquidation process. The Corporate Debtor was admitted into CIRP on 18.01.2023, and Mr. Manjeet Bucha was appointed as IRP. A public announcement was made, inviting claims from creditors. The CoC was formed, and the IRP was appointed as RP on 16.02.2023, confirmed on 27.03.2023. The resolution plan was not approved, and the CIRP failed. Liquidation was initiated on 25.12.2023, and Mr. Rajesh Chillale was appointed as the Liquidator.
Ariston Pharma Nova Tech Private Limited was admitted into Corporate Insolvency Resolution Process (CIRP) on 18.01.2023. The CIRP failed because the resolution plan was not approved by the Committee of Creditors (CoC). Consequently, liquidation was initiated, and Mr. Rajesh Chillale was appointed as the Liquidator. The Liquidator made public announcements, formed a Stakeholders Consultation Committee, and prepared a Preliminary Report and Asset Memorandum. An e-auction was conducted, and Mr. Shankar Sharma emerged as the successful bidder for the sale of the Corporate Debtor as a going concern for Rs. 57,03,000/-. The Liquidator transferred the Corporate Debtor to Mr. Shankar Sharma and issued a Sale Certificate dated 24.07.2024. The full sale consideration was
…Sign in to view the parties.
The Corporate Debtor was admitted into…
The IRP issued a public…
The case involves an application filed under Regulation 45(3)(a) of the IBBI (Liquidation Process) Regulations, 2016, by the Liquidator of Ariston Pharma Nova Tech Private Limited, seeking closure of the liquidation process. The Corporate Debtor was admitted into CIRP on 18.01.2023, and Mr. Manjeet Bucha was appointed as IRP. A public announcement was made, inviting claims from creditors. The CoC was formed, and the IRP was appointed as RP on 16.02.2023, confirmed on 27.03.2023. The resolution plan was not approved, and the CIRP failed. Liquidation was initiated on 25.12.2023, and Mr. Rajesh Chillale was appointed as the Liquidator.
Ariston Pharma Nova Tech Private Limited was admitted into Corporate Insolvency Resolution Process (CIRP) on 18.01.2023. The CIRP failed because the resolution plan was not approved by the Committee of Creditors (CoC). Consequently, liquidation was initiated, and Mr. Rajesh Chillale was appointed as the Liquidator. The Liquidator made public announcements, formed a Stakeholders Consultation Committee, and prepared a Preliminary Report and Asset Memorandum. An e-auction was conducted, and Mr. Shankar Sharma emerged as the successful bidder for the sale of the Corporate Debtor as a going concern for Rs. 57,03,000/-. The Liquidator transferred the Corporate Debtor to Mr. Shankar Sharma and issued a Sale Certificate dated 24.07.2024. The full sale consideration was
…The Corporate Debtor was admitted into…
The IRP issued a public…